Interim Data from Clinical Trial Support MS1819 as Potential Therapy for EPI in CF Patients

March 23, 2023October 2, 2017 by Cystic Fibrosis Educational Services

Current News and Events

CFTR Modulation Research funded by CFFOctober 4, 2017
Interim Data from Clinical Trial Support MS1819 as Potential Therapy for EPI in CF PatientsOctober 2, 2017
Enrollment Underway in CF Clinical Trial for Ear Toxicity Caused by AntibioticsOctober 2, 2017
ProQR’s Inhaled RNA Therapy Improves CF Symptoms in Phase 1 Clinical TrialOctober 2, 2017
CF Patient, Recovering from Double Transplant, Inspires ‘Lunges4Lungs’ FundraiserSeptember 29, 2017
Vizient Awards Alcresta Contract for Relizorb, Which Helps CF Patients Digest Healthy FatsSeptember 29, 2017
What’s Next for the CF Community and Health Care ReformSeptember 7, 2017